One study from 2014 demonstrated that anti-citrullinated protein antibodies (ACPAs) are enriched in BAL fluid of ACPA-positive patients with rheumatoid arthritis, and that these patients also exhibit lung abnormalities during early stages of disease [24]. Here, PRTN3 is linked to rheumatoid arthritis.